|

Effect of Pre-Hospital ARNI Therapy on Short-Term Outcomes in HFrEF

RECRUITINGSponsored by Future University in Egypt
Actively Recruiting
SponsorFuture University in Egypt
Started2026-01-10
Est. completion2026-04-15
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07347925

Summary

This study looks at people with heart failure who are admitted to the hospital. The goal of the study is to understand whether taking a heart failure medicine called angiotensin receptor-neprilysin inhibitor (ARNI) before hospital admission affects short-term health outcomes. The study will compare two groups of participants: those who were already taking ARNI before coming to the hospital and those who were not. Information will be collected from medical records during the hospital stay, including heart-related events, kidney-related events, and how long participants stay in the hospital. Some participants will also be followed for a short period after discharge. This study may help improve understanding of outcomes associated with ARNI use in people with heart failure in routine clinical care.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* \>= 18 years, male or female EF \<40%

Exclusion Criteria:

* EF\>40% Pregnancy or breastfeeding

Conditions2

Heart DiseaseHeart Failure

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.